Detalles de la búsqueda
1.
Long-term open-label safety study of galcanezumab in patients with episodic or chronic cluster headache.
Cephalalgia
; 42(11-12): 1225-1235, 2022 10.
Artículo
Inglés
| MEDLINE | ID: mdl-35633025
2.
Tolerability and safety of galcanezumab in patients with chronic cluster headache with up to 15 months of galcanezumab treatment.
Headache
; 62(1): 65-77, 2022 Jan.
Artículo
Inglés
| MEDLINE | ID: mdl-34806783
3.
Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies.
BMC Neurol
; 20(1): 25, 2020 Jan 17.
Artículo
Inglés
| MEDLINE | ID: mdl-31952501
4.
Correction to: Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies.
BMC Neurol
; 20(1): 90, 2020 03 13.
Artículo
Inglés
| MEDLINE | ID: mdl-32169042
5.
Long-Term, Open-Label, Safety Study of Edivoxetine 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment.
J Clin Psychopharmacol
; 35(3): 266-72, 2015 Jun.
Artículo
Inglés
| MEDLINE | ID: mdl-25815754
6.
A cohort study of the risk of seizures in a pediatric population treated with atomoxetine or stimulant medications.
Pharmacoepidemiol Drug Saf
; 22(4): 386-93, 2013 Apr.
Artículo
Inglés
| MEDLINE | ID: mdl-23280590
7.
Atomoxetine and cerebrovascular outcomes in adults.
J Clin Psychopharmacol
; 29(5): 453-60, 2009 Oct.
Artículo
Inglés
| MEDLINE | ID: mdl-19745645
8.
Hepatic events associated with atomoxetine treatment for attention-deficit hyperactivity disorder.
Drug Saf
; 31(4): 345-54, 2008.
Artículo
Inglés
| MEDLINE | ID: mdl-18366245
9.
Meta-analysis of suicide-related behavior events in patients treated with atomoxetine.
J Am Acad Child Adolesc Psychiatry
; 47(2): 209-218, 2008 Feb.
Artículo
Inglés
| MEDLINE | ID: mdl-18176331
10.
Meta-analysis of aggression or hostility events in randomized, controlled clinical trials of atomoxetine for ADHD.
Biol Psychiatry
; 61(5): 713-9, 2007 Mar 01.
Artículo
Inglés
| MEDLINE | ID: mdl-16996485
11.
Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Clin Ther
; 29(6): 1168-77, 2007 Jun.
Artículo
Inglés
| MEDLINE | ID: mdl-17692731
12.
Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression.
J Child Adolesc Psychopharmacol
; 17(4): 407-20, 2007 Aug.
Artículo
Inglés
| MEDLINE | ID: mdl-17822337
13.
Long-Term, Open-Label, Safety Study of Edivoxetine Monotherapy in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
J Child Adolesc Psychopharmacol
; 27(8): 700-707, 2017 Oct.
Artículo
Inglés
| MEDLINE | ID: mdl-28402139
14.
Efficacy outcomes from 3 clinical trials of edivoxetine as adjunctive treatment for patients with major depressive disorder who are partial responders to selective serotonin reuptake inhibitor treatment.
J Clin Psychiatry
; 77(5): 635-42, 2016 May.
Artículo
Inglés
| MEDLINE | ID: mdl-27035159
15.
Acute and longer-term safety results from a pooled analysis of duloxetine studies for the treatment of children and adolescents with major depressive disorder.
J Child Adolesc Psychopharmacol
; 25(4): 293-305, 2015 May.
Artículo
Inglés
| MEDLINE | ID: mdl-25978741
16.
Safety and tolerability of edivoxetine as adjunctive treatment to selective serotonin reuptake inhibitor antidepressants for patients with major depressive disorder.
Drugs Context
; 4: 212279, 2015.
Artículo
Inglés
| MEDLINE | ID: mdl-26005493
17.
A double-blind efficacy and safety study of duloxetine fixed doses in children and adolescents with major depressive disorder.
J Child Adolesc Psychopharmacol
; 24(4): 170-9, 2014 May.
Artículo
Inglés
| MEDLINE | ID: mdl-24815533
18.
Meta-analysis of suicide-related behavior or ideation in child, adolescent, and adult patients treated with atomoxetine.
J Child Adolesc Psychopharmacol
; 24(8): 426-34, 2014 Oct.
Artículo
Inglés
| MEDLINE | ID: mdl-25019647
19.
A double-blind efficacy and safety study of duloxetine flexible dosing in children and adolescents with major depressive disorder.
J Child Adolesc Psychopharmacol
; 24(4): 180-9, 2014 May.
Artículo
Inglés
| MEDLINE | ID: mdl-24813026
20.
Prospective assessment of suicidal ideation and behavior: an internet survey of pharmaceutical sponsor practices.
Innov Clin Neurosci
; 11(9-10): 14-22, 2014 Sep.
Artículo
Inglés
| MEDLINE | ID: mdl-25520885